Cannabinoids and Adverse Convulsive Effects: A Pharmacovigilance and Addictovigilance Analysis of Cases Reported in France
Fundam Clin Pharmacol. 2025 Laroche ML, Labetoulle M, Jouanjus E, Kröger E, Zongo A.
High-dose use of pregabalin and gabapentin in France: a retrospective, population-based cohort study
Lancet Regional Health. 2025. Soeiro T, Uras M, Jouanjus É, Lapeyre-Mestre M, Micallef J.
Impact of urine drug screening on opioid agonist treatment maintenance with buprenorphine in primary care in France: A cluster-randomized trial.
Therapie. 2025. Dupouy J, Rousseau V, Authier N, Di Patrizio P, Gentile G, Gibaja V, Laporte C, Letrilliart L, Maynié C, Micallef J, Mallaret M, Oustric S, Bérard E, Lapeyre-Mestre M.
Psychiatric and Neurocognitive Adverse Events in Young Users of Nonmedical Nitrous Oxide
Journal of Clinical Psychopharmacology. 2025. Margot Lestienne, Alexandra Macgregor, Laurie Surig, Hélène Donnadieu, Etienne Mondesert, Céline Eiden, Hélène Peyrière, ProtoPsy study group
Le programme POP (Prévention et réduction des risques des surdoses liées aux opioïdes en PACA) : les actions réalisées auprès des professionnels
Douleurs : Évaluation – Diagnostic – Traitement. 2025 Salim Mezaache, Franck Turlure, Nathalie Fredon, Maeva Jego-Sablier, Gaëtan Gentile, Anne Donnet, Michel Lanteri-Minet, Joëlle Micallef, Elisabeth Frauger
Prévention du mésusage et du risque des surdoses d’opioïdes et diffusion de naloxone : état des lieux des pratiques, besoins et perspectives auprès des pharmaciens d’officine
Therapie 2025. Armelle Chan Soc Foh, Salim Mezaache, Franck Turlure, Nathalie Fredon, Stéphane Pichon, Laurent Peillard, Joelle Micallef, Elisabeth Frauger
Non-medical nitrous oxide misuse: From identifying a signal to unprecedented addictovigilance network communication.
Thérapie 2024. Marylène Guerlais 1, Sylvie Deheul 2; FAN 3; Reynald Le Boisselier 4, Caroline Victorri-Vigneau 5
SONOPS multicenter cross-sectional study: Study Of the Nitrous Oxide Perception and use in french dental Students.
Int Dent J. 2025. Mélanie Duval 1, Maud Rodney 2, Morgane Rousselet 3, Choosie Jaquin 2, Elsa Garot 4, Thomas Marquillier 5, Ariane Camoin 6, Marion Strub 7, Mathieu Marty 8, Edouard-Jules Laforgue 3, Caroline Victorri-Vigneau 3, Tony Prud’homme 9
First episode of catatonia followed by a psychotic episode related to chronic nitrous oxide use: A case report.
Taillefer de Laportalière T, Redon M, Roussin A, Willemet E, Very E, Olivier J, Lapeyre-Mestre M. First episode of catatonia followed by a psychotic episode related to chronic nitrous oxide use: A case report. Drug Alcohol Rev. 2025 Feb 3.
Narrative Review of Heart Failure Related to Cocaine Consumption and Its Therapeutic Management.
Alawoè C, Chapet N, Roubille F, Peyrière H, Eiden C. Narrative Review of Heart Failure Related to Cocaine Consumption and Its Therapeutic Management. J Clin Med. 2024 Nov 29;13(23):7275.